Objective: The study was conducted to evaluate outcome of probing for congenital nasolacrimal duct obstruction. It was an interventional study at a tertiary level hospital of Chittagong. Methods: The study was conducted during April 2009 to March 2013 (04 years). Total 120 eyes of 102 children of 1-3 years age group were probed. Minimum follow up time was 01 year. Results: 110 eyes fully cured, 05 eyes needed re-probing, 03 eyes needed Dacrocystorhinostomy operation (DCR) and 02 cases were dropped out. Male female ratio was 72 (60%) and 48 (40%). Conclusion: Outcome of probing is better among 1-2 years age group than that of 2-3 years age group. A discussion is made with updated literature review.
INTRODUCTION
Five percent (5%) newborn babies suffer from Congenital Nasolacrimal Duct Obstruction (CNLDO). This is due to mal-development of nasolacrimal drainage system. Obstruction occurs at different levels: commonest site of obstruction is at valve of Hasner. General stenosis of duct may be there. In some cases maldevelopment of punctum and canaliculi have been observed. Congenital absence of valves and other causes were also recorded.
History and clinical examinations are enough for diagnosis of CNLDO.
Conservative management is usually given up to first birth day. Non respondents are considered for probing and DCR. After all GA fitness probing is done. Standard post operative management with antibiotic and analgesics also needed. Probed patient needs follow up according to a schedule. Some patients need re-probing. Non responding patients need DCR operation 1 .
Mozammel Hoq Sharife . Time of probing is very important. Among 1-2 year age group probing is very rewarding. In our study success rate is 100%. He observed 92% success rate beyond 01 year after birth 3 . He reported 860 cases of probing in 1985. 06% cases needed re-probing and only 0.5% cases needed 3 rd time probing 4 .
CONCLUSION
Probing is very rewarding during 1-2 year age group. A multicenter large scale study may be undertaken before national guideline formulation for management of CNLDO.
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